CURE Media Group Teams With National LeioMyoSarcoma Foundation and...
Partnership expands advocacy and empowerment for patients fighting cancer(PRWeb November 02, 2016)Read the full story at http://www.prweb.com/releases/CURE_MediaGroup/NLMSF_NCCS/prweb13816536.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 3, 2016 Category: Pharmaceuticals Source Type: news
Power morcellation rates plunged after FDA warnings
Use of electric power morcellation for hysterectomy procedures has significantly declined after the FDA warned against the use of such devices in 2014, according to a new study.
Data from the study was published this month in the Journal of the American Medical Association.
The study examined a total of 203,520 women who underwent hysterectomy procedures from 2013 to the 1st quarter of 2015 as recorded in the Perspective database, which includes more than 500 hospitals in the U.S.
Researchers found that the use of power morcellators peaked in the 4th quarter of 2013 at 13.7%, and dropped to only 2.8% by the 1st quarter of ...
Source: Mass Device - August 23, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Food & Drug Administration (FDA) Women's Health Source Type: news
Avoid Morcellation When Malignancy Is SuspectedAvoid Morcellation When Malignancy Is Suspected
Dr Peter Kovacs summarizes a new study that found that morcellation is associated with decreased early survival in women with occult leiomyosarcomas. Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 25, 2016 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Viewpoint Source Type: news
Johnson & Johnson looks to settle morcellator lawsuits
Johnson & Johnson(NYSE:JNJ) is reportedly looking to settle 100s of product liability and wrongful death lawsuits brought over its now-recalled laparoscopic power morcellators used during surgeries to remove ostensibly benign uterine tumors.
The morcellators, which use a cutting tip to shred and remove uterine tissue, have been implicated in the spread of a lethal cancer that can masquerade undetected as benign fibroids.
The FDA in April 2014 issued a warning about the devices, later convening a special advisory panel to evaluate their continued use in the surgical suite. The watchdog agency estimates that about 0....
Source: Mass Device - March 21, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Legal News Product Liability Surgical Ethicon Inc. Johnson & Johnson Source Type: news
Learn About Each Type of Colon Cancer
Adenocarcinoma is the most common type of colon cancer but there are many other forms as well. Examples include leiomyosarcoma, lymphoma, melanoma, and neuroendocrine tumors. Here, you can learn more about each type of colon cancer. (Source: About.com Colon Cancer)
Source: About.com Colon Cancer - March 1, 2016 Category: Cancer & Oncology Authors: coloncancer.guide at about.com Tags: health Source Type: news
Just what is Leiomyosarcoma?
Leiomyosarcomas account for less than two percent of colorectal cancers and have a fairly high chance of spreading. Learn more about leiomyosarcomas. (Source: About.com Colon Cancer)
Source: About.com Colon Cancer - February 26, 2016 Category: Cancer & Oncology Authors: coloncancer.guide at about.com Tags: health Source Type: news
Primary Leiomyosarcoma of the Submandibular GlandPrimary Leiomyosarcoma of the Submandibular Gland
Leiomyosarcoma is a rare malignant mesenchymal tumor; and even rarer in the salivary gland. How was diagnosis ascertained in this case? BMC Clinical Pathology (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - January 29, 2016 Category: Pathology Tags: Pathology & Lab Medicine Journal Article Source Type: news
Janssen's Yondelis gets FDA approval to treat unresectable or metastatic LPS or LMS
Janssen Biotech has received approval from the US Food and Drug Administration (FDA) for Yondelis (trabectedin) to treat patients with unresectable or metastatic liposarcoma (LPS) or leiomyosarcoma (LMS) who received a prior anthracycline-containing … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 26, 2015 Category: Pharmaceuticals Source Type: news
FDA approves new therapy for certain types of advanced soft tissue sarcoma
The U.S. Food and Drug Administration today approved Yondelis (trabectedin), a chemotherapy, for the treatment of specific soft tissue sarcomas (STS) – liposarcoma and leiomyosarcoma – that cannot be removed by surgery (unresectable) or is advanced (metastatic). This treatment is approved for patients who previously received chemotherapy that contained anthracycline. (Source: Food and Drug Administration)
Source: Food and Drug Administration - October 23, 2015 Category: American Health Source Type: news
World's First Partial Skull And Scalp Transplant A Success In Texas
Opening a new frontier in transplant surgery, Texas doctors have done the world's first partial skull and scalp transplant to help a man who suffered a large head wound from cancer treatment.
Doctors from Houston Methodist Hospital and MD Anderson Cancer Center did the operation two weeks ago.
The recipient — Jim Boysen, a 55-year-old software developer from Austin, Texas — expects to leave the hospital Thursday with a new kidney and pancreas along with the scalp and skull grafts. He said he was stunned at how well doctors matched him to a donor with similar skin and hair coloring.
"It's kind of shocking, really, ho...
Source: Science - The Huffington Post - June 5, 2015 Category: Science Source Type: news
World's First Skull-Cap Transplant Helps Jim Boysen Fight Cancer
Opening a new frontier in transplant surgery, Texas doctors have done the world's first partial skull and scalp transplant to help a man who suffered a large head wound from cancer treatment.
Doctors from Houston Methodist Hospital and MD Anderson Cancer Center did the operation two weeks ago.
The recipient - Jim Boysen, a 55-year-old software developer from Austin, Texas - expects to leave the hospital Thursday with a new kidney and pancreas along with the scalp and skull grafts. He said he was stunned at how well doctors matched him to a donor with similar skin and hair coloring.
"It's kind of shocking, really, how go...
Source: Science - The Huffington Post - June 5, 2015 Category: Science Source Type: news
Fibroid Morcellation Gets Boost From New Study (CME/CE)
(MedPage Today) -- But procedure was linked to more leiomyosarcoma deaths. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 25, 2015 Category: Primary Care Source Type: news
Leiomyosarcoma of the Colon and Rectum
Colorectal sarcomas occur in the smooth muscle of the colon and are called leiomyosarcomas. Leiomyosarcomas account for less than two percent of colorectal cancers and have a fairly high chance of spreading. (Source: About.com Colon Cancer)
Source: About.com Colon Cancer - February 22, 2015 Category: Cancer & Oncology Authors: coloncancer.guide at about.com Tags: health Source Type: news
Power Morcellator Cancer Risk Confirmed by FDA, As Bernstein Liebhard...
The FDA's new morcelltor cancer warning comes amid growing concerns that uterine morcellation may have caused numerous women to experience the spread of uterine sarcoma, leiomyosarcoma and other...(PRWeb November 25, 2014)Read the full story at http://www.prweb.com/releases/morcellator-lawsuit/morcellator-cancer/prweb12355345.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 26, 2014 Category: Pharmaceuticals Source Type: news
PharmaMar announces US partner Janssen files NDA for YONDELIS for soft-tissue sarcoma
(Pharmamar) Based on a phase 3 trial in which dacarbazine was used in the comparator arm, Janssen has submitted a NDA for YONDELIS (trabectedin) to the FDA for the treatment of patients with advanced soft tissue sarcoma, including liposarcoma and leiomyosarcoma, who have received prior chemotherapy including an anthracycline. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 25, 2014 Category: Cancer & Oncology Source Type: news
